Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury

Vascular endothelial growth factor pathway inhibitors (VEGFi), used as anti-angiogenic drugs to treat cancer are associated with cardiovascular toxicities through unknown molecular mechanisms. Endothelial cell-derived microparticles (ECMPs) are biomarkers of endothelial injury and are also functiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Neves, Karla B, Rios, Francisco J, Jones, Robert, Evans, Thomas Ronald Jeffry, Montezano, Augusto C, Touyz, Rhian M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452312/
https://www.ncbi.nlm.nih.gov/pubmed/30753341
http://dx.doi.org/10.1093/cvr/cvz021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452312/
https://www.ncbi.nlm.nih.gov/pubmed/30753341
http://dx.doi.org/10.1093/cvr/cvz021

Ejemplares similares